Genitourinary - Refresher 2021 is organized by American Society for Radiation Oncology (ASTRO).
Course opens: 04/12/2021
Course expires: 04/11/2024
Description :
There is a large volume of new data continuously being released about the optimal management of prostate and other genitourinary cancers. It is essential for practicing radiation oncologists to know the latest data and be able to integrate it into daily practice. This course reviews new data and standards of care for each disease state of prostate cancer. Presenters review low-risk disease, intermediate risk, high-risk, locally advanced, node-positive, oligometastatic, post-operative, and recurrent prostate cancer, as well as data on bladder and testicular cancers.
Learning Objectives :
Upon completion of this activity, learners should be able to:
• Treat all risk groups, including oligometastatic prostate cancer, with radiation when appropriate.
• Utilize androgen deprivation therapy with radiation for prostate cancer when appropriate.
• Hypofractionate radiation for prostate cancer when appropriate.
Available Credit:
1.50 Certificate of Attendance
This activity was designated for 1.50 AMA PRA Category 1 Credit™.
1.50 SA-CME
The American Society for Radiation Oncology (ASTRO) is accredited by the Accreditation Council of Continuing Medical Education to provide continuing medical education for physicians.
The American Society for Radiation Oncology (ASTRO) designates this for a maximum of 1.50 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
This activity meets the American Board of Radiology's criteria for a self-assessment activity in the ABR's Maintenance of Certification program. Participation in this course in combination with the successful completion of the corresponding assessment and course evaluation adheres to the guidelines established by the ABR for 1.50 self-assessment credits.
Copyrights © 2026 eMedEvents Corporation, All Rights Reserved